{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:32:19Z","timestamp":1787243539734,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118843","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:34:43Z","timestamp":1764765283000},"page":"118843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Niosomal co-delivery of metformin and telaglenastat: A targeted nanotherapeutic strategy for breast cancer treatment and metastasis suppression in 2D and 3D models"],"prefix":"10.1016","volume":"193","author":[{"given":"Ahlam","family":"Zaid Alkilani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen A.","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1575-9893","authenticated-orcid":false,"given":"Maram A.","family":"Alhusban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walhan","family":"Alshaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118843_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.reactfunctpolym.2021.104970","article-title":"Recent advances in nanocarriers-based drug delivery for cancer therapeutics: A review","volume":"165","author":"Yadav","year":"2021","journal-title":"React. Funct. Polym."},{"issue":"2","key":"10.1016\/j.biopha.2025.118843_bib2","first-page":"17","article-title":"Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies","volume":"9","author":"Nounou","year":"2015","journal-title":"Breast Cancer (Auckl)"},{"issue":"11","key":"10.1016\/j.biopha.2025.118843_bib3","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","article-title":"Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023","volume":"34","author":"Curigliano","year":"2023","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib4","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a cancer journal clinicians"},{"key":"10.1016\/j.biopha.2025.118843_bib5","article-title":"The Metabolic Mechanisms of Breast Cancer Metastasis","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.118843_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154791","article-title":"Hormone receptors in breast cancer: An update on the uncommon subtypes","volume":"250","author":"Wei","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"17","key":"10.1016\/j.biopha.2025.118843_bib7","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.3390\/cancers17172938","article-title":"The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer","volume":"17","author":"Kannan","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118843_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115464","article-title":"Glutamine metabolism in breast cancer and possible therapeutic targets","volume":"210","author":"Li","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib9","doi-asserted-by":"crossref","first-page":"34135","DOI":"10.1038\/s41598-025-03123-3","article-title":"Clinicopathological analysis of GLUT-1, GLS1, and GLS2 expression in breast cancer tissues from Jordanian patients","volume":"15","author":"Basheer","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5483\/BMBRep.2017.50.3.189","article-title":"Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.biopha.2025.118843_bib11","first-page":"232","article-title":"Nanoparticles-based Chemo-Phototherapy Synergistic Effects for Breast Cancer Treatment: A Systematic Review","volume":"13","author":"Radzi","year":"2023","journal-title":"Biointerface Res. Appl. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2025.118843_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12032-022-01836-3","article-title":"Niosomes: a novel targeted drug delivery system for cancer","volume":"39","author":"Moghtaderi","year":"2022","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118843_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12032-023-02032-7","article-title":"Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells","volume":"40","author":"Firouzi Amandi","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2025.118843_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomater. Res"},{"key":"10.1016\/j.biopha.2025.118843_bib15","series-title":"in Advances in Nanotechnology-Based Drug Delivery Systems","first-page":"133","article-title":"Clinical potential of nanotechnlogy as smart therapeutics: A step toward targeted drug delivery","author":"Saha","year":"2022"},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for cancer therapy: current progress and challenges","volume":"16","author":"Gavas","year":"2021","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12935-024-03219-2","article-title":"Fabrication of magnetic niosomal platform for delivery of resveratrol: potential anticancer activity against human pancreatic cancer Capan-1 cell","volume":"24","author":"Firouzi Amandi","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.31557\/APJCP.2022.23.3.919","article-title":"Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment","volume":"23","author":"Khoshravan","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"20","key":"10.1016\/j.biopha.2025.118843_bib19","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.3390\/nano12203570","article-title":"Formulation and evaluation of niosomal alendronate sodium encapsulated in polymeric microneedles: in vitro studies, stability study and cytotoxicity study","volume":"12","author":"Zaid Alkilani","year":"2022","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/ntrev-2022-0010","article-title":"Glutathione-loaded non-ionic surfactant niosomes: A new approach to improve oral bioavailability and hepatoprotective efficacy of glutathione","volume":"11","author":"Aboubakr","year":"2022","journal-title":"Nanotechnol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.118843_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/pharmaceutics11020055","article-title":"Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery","volume":"11","author":"Ge","year":"2019","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.biopha.2025.118843_bib22","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.3390\/molecules27175418","article-title":"pH-Responsive PEGylated niosomal nanoparticles as an active-targeting cyclophosphamide delivery system for gastric cancer therapy","volume":"27","author":"Khodabakhsh","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010067","article-title":"Niosome Preparation Techniques and Structure-An Illustrated Review","volume":"17","author":"Mawazi","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118843_bib24","volume":"8","author":"Nanotechnol","year":"2023","journal-title":"Nanomed. Nanotechnol. Open Access"},{"key":"10.1016\/j.biopha.2025.118843_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121878","article-title":"A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system","volume":"624","author":"Yasamineh","year":"2022","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2025.118843_bib26","first-page":"27","article-title":"Niosomes: recent advances and applications in targeted drug delivery","author":"Nguyen","year":"2024","journal-title":"Sci. Technol. Dev. J."},{"issue":"19","key":"10.1016\/j.biopha.2025.118843_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194696","article-title":"Rapid Microfluidic Preparation of Niosomes for Targeted Drug Delivery","volume":"20","author":"Ag Seleci","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118843_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10555-015-9586-9","article-title":"The challenge of targeting metastasis","volume":"34","author":"Fidler","year":"2015","journal-title":"Cancer Metastas.. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2025.118843_bib29","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the hallmarks of metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118843_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100095","article-title":"pH-sensitive oleuropein-loaded niosome: Efficient treatment for metastatic brain tumors in initial steps in-vivo","volume":"8","author":"Al-Jammal","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.biopha.2025.118843_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122303","article-title":"Micellar nanoparticles inhibit the postoperative inflammation, recurrence and pulmonary metastasis of 4T1 breast cancer by blocking NF-\u03baB pathway and promoting MDSCs depletion","volume":"628","author":"Lu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118843_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100083","article-title":"Nanovesicles based drug targeting to control tumor growth and metastasis","volume":"7","author":"Ansari","year":"2023","journal-title":"Adv. Cancer Biol. Metastas.."},{"key":"10.1016\/j.biopha.2025.118843_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2023.100103","article-title":"An insight of various vesicular systems, erythrosomes, and exosomes to control metastasis and cancer","volume":"7","author":"Patil","year":"2023","journal-title":"Adv. Cancer Biol. Metastas.."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2025.118843_bib34","article-title":"Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies","volume":"239","author":"Amiri","year":"2023","journal-title":"Environ. Res"},{"key":"10.1016\/j.biopha.2025.118843_bib35","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fbioe.2024.1482637","article-title":"Self-assembled lipid-based nanoparticles for chemotherapy against breast cancer","volume":"12","author":"Liu","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118843_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091860","article-title":"Polymeric Micelles for Breast Cancer Therapy: Recent Updates, Clinical Translation and Regulatory Considerations","volume":"14","author":"Junnuthula","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12935-025-03977-7","article-title":"Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study","volume":"25","author":"Salemi","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"20","key":"10.1016\/j.biopha.2025.118843_bib38","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.3390\/cancers15205004","article-title":"Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment","volume":"15","author":"Basheer","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biopha.2025.118843_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17070900","article-title":"Development and Characterization of Optimized Drug-Loaded Niosomes for Delivery of 5-FU and Irinotecan","volume":"17","author":"Agbaje","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118843_bib40","first-page":"1","article-title":"Charge reversal nano-systems for tumor therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.118843_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120935","article-title":"Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy","volume":"308","author":"Ahmadi","year":"2022","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118843_bib42","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s43440-020-00154-7","article-title":"Thiadiazole derivatives as anticancer agents","volume":"72","author":"Szeliga","year":"2020","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118843_bib43","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118843_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/pharmaceutics13020295","article-title":"Augmented therapeutic potential of glutaminase inhibitor CB839 in glioblastoma stem cells using gold nanoparticle delivery","volume":"13","author":"Giesen","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.biopha.2025.118843_bib45","article-title":"Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies","volume":"15","author":"El-Far","year":"2022","journal-title":"Pharm. (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13058-022-01538-8","article-title":"Know thy cells: commonly used triple-negative human breast cancer cell lines carry mutations in RAS and effectors","volume":"24","author":"Wagner","year":"2022","journal-title":"Breast Cancer Res."},{"issue":"18","key":"10.1016\/j.biopha.2025.118843_bib47","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-21-1204","article-title":"A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors","volume":"27","author":"Harding","year":"2021","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118843_bib48","unstructured":"National Center for Biotechnology Information (2025). PubChem Compound Summary for CID 71577426, T.R.A., 2025 from \u3008https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Telaglenastat\u3009."},{"key":"10.1016\/j.biopha.2025.118843_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s42452-019-1768-6","article-title":"Formulation and evaluation of metformin hydrochloride-loaded curcumin\u2013lycopene niosomes","volume":"1","author":"Katrolia","year":"2019","journal-title":"SN Appl. Sci."},{"issue":"21","key":"10.1016\/j.biopha.2025.118843_bib50","first-page":"1","article-title":"Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization","author":"Sankhyan","year":"2013","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118843_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.apsusc.2017.11.055","article-title":"Hydrogen bonded niosomes for encapsulation and release of hydrophilic and hydrophobic anti-diabetic drugs: An efficient system for oral anti-diabetic formulation","volume":"449","author":"Samed","year":"2018","journal-title":"Appl. Surf. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118843_bib52","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1158\/1078-0432.CCR-09-1805","article-title":"Metformin: a therapeutic opportunity in breast cancer","volume":"16","author":"Gonzalez-Angulo","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118843_bib53","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41401-020-00508-0","article-title":"Metformin and cancer immunity","volume":"41","author":"Ma","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"48","key":"10.1016\/j.biopha.2025.118843_bib54","doi-asserted-by":"crossref","first-page":"30008","DOI":"10.1039\/C7RA01736G","article-title":"Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers","volume":"7","author":"Naderinezhad","year":"2017","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.biopha.2025.118843_bib55","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.3390\/molecules30173467","article-title":"A Comprehensive Review of Niosomes: Composition, Structure, Formation, Characterization, and Applications in Bioactive Molecule Delivery Systems","volume":"30","author":"Bautista-Solano","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118843_bib56","article-title":"Spheroids in cancer research: Recent advances and opportunities","volume":"100","author":"Arora","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2025.118843_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123184","article-title":"Multicellular tumor spheroids: A convenient in vitro model for translational cancer research","volume":"358","author":"Patel","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118843_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115593","article-title":"Size-dependent penetration depth of colloidal nanoparticles into cell spheroids","volume":"222","author":"Zhu","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.biopha.2025.118843_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212200","article-title":"3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118843_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/00032719.2023.2180516","volume":"56","author":"Nasereddin","year":"2023","journal-title":"Anal. Lett."},{"key":"10.1016\/j.biopha.2025.118843_bib61","article-title":"Formulation and evaluation of nasal insert for nose-to-brain drug delivery of rivastigmine tartrate","volume":"76","author":"Shaghlil","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118843_bib62","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00044-025-03455-9","article-title":"Identification and evaluation of potent AAK1 inhibitors through structure-based pharmacophores, virtual screening and bioassay screening","volume":"34","author":"Al-Sha\u2019er","year":"2025","journal-title":"Med. Chem. Res."},{"issue":"138","key":"10.1016\/j.biopha.2025.118843_bib63","doi-asserted-by":"crossref","DOI":"10.3791\/57691","article-title":"Optimized Scratch Assay for In Vitro Testing of Cell Migration with an Automated Optical Camera","author":"Vang Mouritzen","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"8","key":"10.1016\/j.biopha.2025.118843_bib64","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/polym15081962","article-title":"Development and evaluation of an innovative approach using niosomes based polymeric microneedles to deliver dual antioxidant drugs","volume":"15","author":"Zaid Alkilani","year":"2023","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.biopha.2025.118843_bib65","first-page":"1","article-title":"Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes","volume":"17","author":"Nowroozi","year":"2018","journal-title":"Iran. J. Pharm. Res. IJPR"},{"issue":"57","key":"10.1016\/j.biopha.2025.118843_bib66","doi-asserted-by":"crossref","first-page":"32621","DOI":"10.1039\/C8RA06362A","article-title":"Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy","volume":"8","author":"Agarwal","year":"2018","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib67","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41467-024-46331-7","article-title":"Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2025.118843_bib68","article-title":"Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes","volume":"4","author":"Essa","year":"2014","journal-title":"Asian J. Pharm. (AJP)"},{"key":"10.1016\/j.biopha.2025.118843_bib69","article-title":"Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique","volume":"58","author":"Khan","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib70","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijpharm.2017.07.083","article-title":"Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus","volume":"530","author":"Maestrelli","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118843_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/polym15081962","article-title":"Development and Evaluation of an Innovative Approach Using Niosomes Based Polymeric Microneedles to Deliver Dual Antioxidant Drugs","volume":"15","author":"Zaid Alkilani","year":"2023","journal-title":"Polymers"},{"issue":"12","key":"10.1016\/j.biopha.2025.118843_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12369","article-title":"The effect of noisome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line","volume":"8","author":"Ugorji","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118843_bib73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.msec.2015.06.049","article-title":"Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: An efficient carrier for cancer multi-drug delivery","volume":"56","author":"Sharma","year":"2015","journal-title":"Materials Science Engineering C"},{"key":"10.1016\/j.biopha.2025.118843_bib74","doi-asserted-by":"crossref","unstructured":"Samimi, S., et al., Chapter 3 - Lipid-Based Nanoparticles for Drug Delivery Systems, in Characterization and Biology of Nanomaterials for Drug Delivery, S.S. Mohapatra, et al., Editors. 2019, Elsevier. p. 47-76.","DOI":"10.1016\/B978-0-12-814031-4.00003-9"},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12896-023-00825-2","article-title":"Fabrication and characterization of metformin-loaded PLGA\/Collagen nanofibers for modulation of macrophage polarization for tissue engineering and regenerative medicine","volume":"23","author":"Firouzi Amandi","year":"2023","journal-title":"BMC Biotechnol."},{"issue":"3-4","key":"10.1016\/j.biopha.2025.118843_bib76","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/10717544.2013.779329","article-title":"Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride","volume":"20","author":"Momoh","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118843_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15205004","article-title":"Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment","volume":"15","author":"Basheer","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12668-024-01739-9","article-title":"Evaluating Niosomes Cytotoxicity on Fibroblast Cells: A Preliminary Step Towards Cancer Cell Assessment Using Telaglenastat as a Model Drug","volume":"15","author":"Basheer","year":"2024","journal-title":"BioNanoScience"},{"issue":"56","key":"10.1016\/j.biopha.2025.118843_bib79","doi-asserted-by":"crossref","first-page":"35110","DOI":"10.1039\/D1RA06057K","article-title":"Mechanistic insights into encapsulation and release of drugs in colloidal niosomal systems: biophysical aspects","volume":"11","author":"Judy","year":"2021","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.biopha.2025.118843_bib80","article-title":"Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review","volume":"13","author":"Bai","year":"2022","journal-title":"Micro (Basel)"},{"issue":"5","key":"10.1016\/j.biopha.2025.118843_bib81","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1039\/D3NA01016C","volume":"6","author":"Sangkana","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib82","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0975-1483.83758","article-title":"Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion","volume":"3","author":"Jagdale","year":"2011","journal-title":"J. Young.. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09099","article-title":"Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment","volume":"8","author":"Kenechukwu","year":"2022","journal-title":"Heliyon"},{"issue":"31","key":"10.1016\/j.biopha.2025.118843_bib84","doi-asserted-by":"crossref","first-page":"33542","DOI":"10.1021\/acsomega.4c01224","article-title":"Transdermal Delivery System of Doxycycline-Loaded Niosomal Gels: Toward Enhancing Doxycycline Stability","volume":"9","author":"Zaid Alkilani","year":"2024","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.biopha.2025.118843_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102414","article-title":"Development, Characterization and Pharmacological Evaluation of Cannabidiol-Loaded Long Circulating Niosomes","volume":"15","author":"Gugleva","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib86","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2478\/acph-2025-0026","article-title":"Niosome-based delivery systems for olanzapine: Formulation, characterisation, and kinetic evaluation","volume":"75","author":"Alhabardi","year":"2025","journal-title":"Acta Pharm."},{"issue":"16","key":"10.1016\/j.biopha.2025.118843_bib87","doi-asserted-by":"crossref","first-page":"11124","DOI":"10.1039\/D4RA01334D","article-title":"pH-responsive niosome-based nanocarriers of antineoplastic agents","volume":"14","author":"Gugleva","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2025.118843_bib88","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bcp.2018.08.032","article-title":"Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells","volume":"156","author":"Peyton","year":"2018","journal-title":"Biochem Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118843_bib89","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib90","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine Metabolism in Cancer: Understanding the Heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118843_bib91","first-page":"114","article-title":"GLUT-1 Expression in Breast Cancer","volume":"38","author":"Okcu","year":"2022","journal-title":"Turk. Patoloji Derg."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10863-007-9080-3","article-title":"Hypoxia, glucose metabolism and the Warburg\u2019s effect","volume":"39","author":"Bartrons","year":"2007","journal-title":"J. Bioenerg. Biomembr."},{"issue":"6","key":"10.1016\/j.biopha.2025.118843_bib93","article-title":"Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology","volume":"17","author":"Hristova-Panusheva","year":"2024","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.biopha.2025.118843_bib94","article-title":"Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities","volume":"95","author":"Rashidi","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118843_bib95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1741-7015-9-33","article-title":"Understanding the benefit of metformin use in cancer treatment","volume":"9","author":"Dowling","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.biopha.2025.118843_bib96","article-title":"The potential of metformin nanoformulations for cancer prevention and therapy","volume":"101","author":"Hejazian","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118843_bib97","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ctrv.2015.03.002","article-title":"Metformin and breast cancer: Basic knowledge in clinical context","volume":"41","author":"Pizzuti","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.biopha.2025.118843_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108366","article-title":"The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer","volume":"787","author":"Delgir","year":"2021","journal-title":"Mutat. Res. \/Rev. Mutat. Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118843_bib99","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2025.118843_bib100","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1007\/s11033-022-08171-w","article-title":"Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application","volume":"50","author":"Jafari-Gharabaghlou","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2025.118843_bib101","article-title":"Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer","volume":"71","author":"Loo","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2025.118843_bib102","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2019.03.015","article-title":"Threatening cancer with nanoparticle aided combination oncotherapy","volume":"301","author":"Rawal","year":"2019","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.biopha.2025.118843_bib103","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bcp.2012.01.008","article-title":"Nanoparticle-based combination therapy toward overcoming drug resistance in cancer","volume":"83","author":"Hu","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118843_bib104","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4161\/cbt.9.9.11432","article-title":"MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity","volume":"9","author":"Leung","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib105","article-title":"Evaluation of Anticancer Effects of Curcumin on Multicellular Breast Cancer Spheroids","volume":"37","author":"Farahani","year":"2022","journal-title":"Turk. J. Oncol. \/T\u00fcrk Onkol. Derg."},{"issue":"5","key":"10.1016\/j.biopha.2025.118843_bib106","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/acs.bioconjchem.9b00136","article-title":"Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids","volume":"30","author":"Tchoryk","year":"2019","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biopha.2025.118843_bib107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcdb.2019.05.012","article-title":"Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer","volume":"98","author":"Mat\u00e9s","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118843_bib108","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acs.molpharmaceut.8b01078","article-title":"Role of Endocytosis in Nanoparticle Penetration of 3D Pancreatic Cancer Spheroids","volume":"16","author":"Durymanov","year":"2019","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.biopha.2025.118843_bib109","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118843_bib110","article-title":"Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles","volume":"39","author":"Shinde","year":"2022","journal-title":"Photo Photo Ther."},{"key":"10.1016\/j.biopha.2025.118843_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116545","article-title":"Enhanced penetration and cytotoxicity of metformin and collagenase conjugated gold nanoparticles in breast cancer spheroids","volume":"231","author":"Abdolahinia","year":"2019","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118843_bib112","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1021\/acs.molpharmaceut.9b00107","article-title":"Shape Effect of Nanoparticles on Tumor Penetration in Monolayers Versus Spheroids","volume":"16","author":"Zhang","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118843_bib113","doi-asserted-by":"crossref","first-page":"188","DOI":"10.34172\/apb.2021.020","article-title":"The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells","volume":"11","author":"Meiyanto","year":"2020","journal-title":"Adv. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.biopha.2025.118843_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232565","article-title":"An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays","volume":"15","author":"Suarez-Arnedo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118843_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114187","article-title":"Invasiveness modulation of glioma cells by copper complex-loaded nanoarchitectures","volume":"245","author":"Zamborlin","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2025.118843_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114943","article-title":"Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis","volume":"198","author":"Sharma","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118843_bib117","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2174\/1871520622666220905142338","article-title":"Targeting Glutaminolysis to Treat Multiple Myeloma: An In Vitro Evaluation of Glutaminase Inhibitors Telaglenastat and Epigallocatechin-3-gallate","volume":"23","author":"Li","year":"2023","journal-title":"AntiCancer Agents Med. Chem. AntiCancer Agents"},{"key":"10.1016\/j.biopha.2025.118843_bib118","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2020.12.038","article-title":"Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models","volume":"502","author":"Wicker","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118843_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010049","article-title":"Metformin Impairs Glutamine Metabolism and Autophagy in Tumour Cells","volume":"8","author":"Saladini","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.biopha.2025.118843_bib120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cmet.2016.09.005","article-title":"Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers","volume":"24","author":"Liu","year":"2016","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.biopha.2025.118843_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153199","article-title":"Patterns of cell death induced by metformin in human MCF-7 breast cancer cells","volume":"216","author":"Dias Lopes","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"8","key":"10.1016\/j.biopha.2025.118843_bib122","article-title":"Metformin-ROS-Nrf2 connection in the host defense mechanism against oxidative stress, apoptosis, cancers, and ageing","volume":"1866","author":"Udono","year":"2022","journal-title":"Biochim. Et. Biophys. Acta (BBA) Gen. Subj."},{"key":"10.1016\/j.biopha.2025.118843_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109342","article-title":"Metformin ameliorates 5-fluorouracil-induced intestinalinjury by inhibiting cellular senescence, inflammation, and oxidative stress","volume":"113","author":"Xia","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118843_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107720","article-title":"Synergistic effects of Metformin and Forskolin on oxidative stress induced by diabetes and hepatocellular cancer: An animal study","volume":"243","author":"Yang","year":"2024","journal-title":"Toxicon"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:55:05Z","timestamp":1777013705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225010376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":124,"alternative-id":["S0753332225010376"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118843","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niosomal co-delivery of metformin and telaglenastat: A targeted nanotherapeutic strategy for breast cancer treatment and metastasis suppression in 2D and 3D models","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118843"}}